Max is a pharmaceutical scientist and healthcare strategist with 15+ years of experience translating clinical evidence into real-world outcomes across biopharma, academia, and hospital systems.
He has led cross-functional teams supporting late-stage development and lifecycle strategy for therapies in oncology and immunology, with a focus on evidence generation, patient access, and responsible innovation.